Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vascepa for COVID-19 Prevention and Treatment (PREPARE-IT)
NCT04460651Phase 3Completed
- Sponsor
- ECLA
- Start
- Aug 2020
- Primary completion
- Aug 2021
- Countries
- 1
01
Overview
A Phase 3 trial of omega-3-acid triglycerides in coronavirus disease 2019 (COVID-19), sponsored by ECLA. Started Aug 2020; status: completed.
02
Drugs
omega-3-acid triglycerides
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04460651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04460651.